Mining and Metals, Biotech Valuations, Asymmetric Investing, and More...

Here's the latest from Wealthy Retirement... [Wealthy Retirement]( SPONSORED [He Bought $380 Million Worth of a $2 Crypto!]( [Blurred Out Crypto Investor]( One of the earliest Bitcoin investors, who runs a billion-dollar crypto fund... just SOLD most of his Bitcoin and put $380 million into a $2 crypto. [Shocking Story Here.]( Editor's Note: In a first for The Oxford Club, we are hosting a live virtual trivia game show - the [Oxford Investing Games]( - at 1 p.m. on Wednesday, October 27. And since so many of the trivia answers lie hidden in the articles linked below, you are at a distinct advantage over the competition. With a $10,000 grand prize and more on the line, that advantage could go a long way... And you'll even get a free ticker symbol just for watching. [Come on and sign up for the games here!]( - Kyle Wehrle, Assistant Managing Editor – THE BIG REVEAL – [Dividend Safety Grade]( In this week's Safety Net, Research Associate Brittan Gibbons-O'Neill vetted the dividend safety of a 2.8%-yielding biotech leader. Seeing as many biotechs lack revenue and derive their valuations entirely from drug trial updates, the fact this biotech has paid out a steady dividend since 2017 is exceptional. So how does the company do it? [Learn how from Brittan in this week's Safety Net](. – CHART OF THE WEEK – [Metal and Mining Companies Are on Sale]( As Contributing Analyst Jody Chudley explained on Tuesday, global metals and mining stocks are trading at the biggest discount in years. Among these criminally discounted, inflation-buffering stocks is Cenovus Energy (NYSE: CVE), which carries a 27% free cash flow yield. And if Washington has its way and infrastructure chugs along, Cenovus is just getting started... [Follow Jody's thoughts by clicking here.]( – OVERHEARD – "You have increased the diversification of my portfolio, provided new investment strategies, and made bond investing sensible at last." - Wealthy Retirement Reader J.T. Have an experience that you'd like to share with the team at Wealthy Retirement? [Click here to send us a message.](mailto:mailbag@oxfordclub.com) SPONSORED [Have you heard of Stockflation?]( [Money Flowing]( Former Chicago Board Options Exchange trader reveals how you can tap into this $11.2 trillion force... Protect your cash... And help save your retirement. [Prepare Now - Watch This]( – TOP ARTICLES – [Image of Researchers in a Lab]( [THE SECRET TO SUCCESSFUL INVESTING IN BIOTECH]( On Monday, Marc discussed how biotechs that lack revenue are valued based on the likelihood of their drugs getting approval and flying off the shelves at pharmacies. Smart speculation on the outcome of a drug's approval can lead an investor to incredible gains... [Read how here.]( [Image of a Businessman Flipping a Coin]( [GET AHEAD WITH ASYMMETRIC INVESTMENTS]( The best investments come with a whole lot of upside and little downside. On Thursday, Jody explained how this mix of offensive and defensive investing principles, otherwise known as asymmetric investing, maximizes your chances for success... [Click here to learn more.]( [Image of a Bioreactor]( [HOW TO LOWER RISK ON YOUR BIOTECH PLAYS]( On Friday, Marc explained why early-stage biotech companies are unique. Whereas companies in other sectors typically go public with earnings and cash flow, biotechs often go public without any revenue. Nevertheless, there's plenty of value at stake... [Learn why here.]( [Oxford Investing Games]( – MORE FROM OUR NETWORK OF EXPERTS – [Find the Next Disrupter With These Three Laws of Technology]( [What Is Short Selling?]( [What Makes a Market Wizard?]( [Facebook]( [Facebook]( [Twitter]( [Twitter]( SPONSORED [Controversy]( [The Oxford Club]( You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Wealthy Retirement]( | [Unsubscribe]( © 2021 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [877.808.9795](#) | International: [443.353.4621](#) [Oxfordclub.com]( The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.